Artificial Intelligence in Prostate Cancer Diagnosis on Magnetic Resonance Imaging: Time for a New PARADIGM.

Authors

Ng AB,Giganti F,Kasivisvanathan V

Affiliations (3)

  • Division of Surgery and Interventional Science, University College London, London, UK; Centre for Urology Imaging, Prostate, AI and Surgical Studies (COMPASS) Research Group, University College London, London, UK.
  • Division of Surgery and Interventional Science, University College London, London, UK; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Division of Surgery and Interventional Science, University College London, London, UK; Centre for Urology Imaging, Prostate, AI and Surgical Studies (COMPASS) Research Group, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK. Electronic address: [email protected].

Abstract

Artificial intelligence (AI) may provide a solution for improving access to expert, timely, and accurate magnetic resonance imaging (MRI) interpretation. The PARADIGM trial will provide level 1 evidence on the role of AI in the diagnosis of prostate cancer on MRI.

Topics

Prostatic NeoplasmsArtificial IntelligenceMagnetic Resonance ImagingEditorial

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.